lonicera japonica

Botanicalexperimental

Lonicera japonica, known as Japanese honeysuckle and golden-and-silver honeysuckle, is a species of honeysuckle native to East Asia, including many parts of China. It is often grown as an ornamental plant, but has become an invasive species in a number of countries. It is used in traditional Chinese medicine. — Wikipedia

Clinical trial activity

4 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
1

Earliest trial started Sep 1, 2006 (NCT00704236)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gc6101a
  • lonicera japonica
  • lonicera spp

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04008901Phase 3Feb 13, 2017Seoul National University
NCT02353039Phase 2Sep 1, 2014Clinical Research Solutions, C&R Research, Inc., Green Cross Corporation, Yonsei University
NCT01979926Phase 2Nov 1, 2013Korea Pharmaceutical Manufacturers Association, PharmaKing
NCT00704236Phase 4Sep 1, 2006Jiao Tong University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Clinical Research SolutionsFor profit1012014
C&R Research, Inc.For profit1012014
Green Cross CorporationFor profit1112014
Jiao Tong UniversityAcademic/Hospital1112006
Korea Pharmaceutical Manufacturers AssociationFor profit1012013
PharmaKingFor profit1112013
Seoul National UniversityAcademic/Hospital1112017
Yonsei UniversityAcademic/Hospital1012014
8 organizations
Page 1 / 1